Intraperitoneal injection of purified recombinant Acrp30 lowers glucose levels in mice. To gain insight into the mechanism(s) of this hypoglycemic effect, purified recombinant Acrp30 was infused in conscious mice during a pancreatic euglycemic clamp. In the presence of physiological hyperinsulinemia, this treatment increased circulating Acrp30 levels by approximately twofold and stimulated glucose metabolism. The effect of Acrp30 on in vivo insulin action was completely accounted for by a 65% reduction in the rate of glucose production. Similarly, glucose flux through glucose-6-phosphatase (G6Pase) decreased with Acrp30, whereas the activity of the direct pathway of glucose-6-phosphate biosynthesis, an index of hepatic glucose phosphorylation, increased significantly. Acrp30 did not affect the rates of glucose uptake, glycolysis, or glycogen synthesis. These results indicate that an acute increase in circulating Acrp30 levels lowers hepatic glucose production without affecting peripheral glucose uptake. Hepatic expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and G6Pase mRNAs was reduced by more than 50% following Acrp30 infusion compared with vehicle infusion. Thus, a moderate rise in circulating levels of the adipose-derived protein Acrp30 inhibits both the expression of hepatic gluconeogenic enzymes and the rate of endogenous glucose production.
Terry P. Combs, Anders H. Berg, Silvana Obici, Philipp E. Scherer, Luciano Rossetti
Title and authors | Publication | Year |
---|---|---|
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2
M Ishikawa, J Kitayama, T Yamauchi, T Kadowaki, T Maki, H Miyato, H Yamashita, H Nagawa |
Cancer Science | 2007 |
Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus
M Bajaj, S Suraamornkul, LJ Hardies, L Glass, N Musi, RA DeFronzo |
Diabetologia | 2007 |
Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women
JK Nien, S Mazaki-Tovi, R Romero, O Erez, JP Kusanovic, F Gotsch, BL Pineles, R Gomez, S Edwin, M Mazor, J Espinoza, BH Yoon, SS Hassan |
Journal of Perinatal Medicine | 2007 |
Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells
I Kanazawa, T Yamaguchi, S Yano, M Yamauchi, M Yamamoto, T Sugimoto |
BMC cell biology | 2007 |
Adiponectin in severe preeclampsia
JK Nien, S Mazaki-Tovi, R Romero, O Erez, JP Kusanovic, F Gotsch, BL Pineles, R Gomez, S Edwin, M Mazor, J Espinoza, BH Yoon, SS Hassan |
Journal of Perinatal Medicine | 2007 |
Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis
LJ Zhao, H Jiang, CJ Papasian, D Maulik, B Drees, J Hamilton, HW Deng |
Journal of Bone and Mineral Research | 2007 |
Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes
L Cong, K Chen, J Li, P Gao, Q Li, S Mi, X Wu, AZ Zhao |
Biochemical Journal | 2007 |
Adipokines and vascular disease in diabetes
BJ Goldstein, R Scalia |
Current Diabetes Reports | 2007 |
Pathophysiological significance of adiponectin
M Nishida, T Funahashi, I Shimomura |
Medical Molecular Morphology | 2007 |
Relationship among Adiponectin, Adiponectin Gene Expression and Fatty Acids Composition in Morbidly Obese Patients
JJ Hernandez-Morante, FI Milagro, E Larque, J Lujan, JA Martinez, S Zamora, M Garaulet |
Obesity Surgery | 2007 |
Peripheral Disruption of the Grb10 Gene Enhances Insulin Signaling and Sensitivity In Vivo
L Wang, B Balas, CY Christ-Roberts, RY Kim, FJ Ramos, CK Kikani, C Li, C Deng, S Reyna, N Musi, LQ Dong, RA DeFronzo, F Liu |
Molecular and cellular biology | 2007 |
Nutrigenomics, beta-cell function and type 2 diabetes.
Nino-Fong R, Collins T, Chan C |
Current genomics | 2007 |